Revised Redemption Agreement with Global Pharm

Adamas Finance Asia Limited

(the "Company")

REVISED REDEMPTION AGREEMENT WITH Global Pharm

On 21 October 2015, the Company announced that it had, through its 75% owned subsidiary, Blazer Delight Limited ("Blazer Delight"), entered into a revised agreement for the redemption of the remainder of its convertible bond held in Global Pharm Holdings Group Inc. ("Global Pharm") (the "Revised Agreement").

Through its investment manager, Adamas Global Alternative Investment Management Inc. ("Adamas GAIM"), the Company has been notified that due to working capital commitments relating to the purchase of ginseng during the current harvest season, Global Pharm will not make the two monthly payments of US$750,000 (net to the Company) in respect of September and October 2015 by 31 October 2015 when they fall due. Global Pharm has indicated to Adamas GAIM that it intends to make the overdue payments in November.

The Revised Agreement provides that monthly payments are subject to Global Pharm's working capital requirements. However, in accordance with the Revised Agreement, Global Pharm Holdings Limited, LLC ("GPHL"), a major shareholder in Global Pharm, will transfer shares in Global Pharm to Blazer Delight equivalent to 0.00375% (net to the Company) of Global Pharm's outstanding ordinary share capital in respect of each payment which is not made by 30 days after the due date. Any such shares will be transferred on the first business day of each year commencing in 2016 and will be transferred back to GPHL in the event that payment of the entire outstanding balance is made by 30 April 2019 or the achievement of a qualifying IPO by Global Pharm, whichever is the earlier.

Enquiries: